FDA tags Editas’ thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic
FDA tags Editas’ thalassemia cell therapy an orphan drug as [...]
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug
Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps [...]
Chutes & Ladders—Moderna CFO Gomez departs after just one day following unearthed investigation
Chutes & Ladders—Moderna CFO Gomez departs after just one day [...]
Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race
Bristol Myers provides Bridge over troubled water with $905M deal [...]
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom
After 20 years, Boehringer vet hits the exit to become [...]
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data
Bristol Myers on track for 3rd new drug launch of [...]
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T [...]
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute ‘false and speculative narrative’ at trial
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging [...]
Welcome to new (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal
Welcome to new (Bio) Haven: CEO hopes to strike gold [...]
Novo Nordisk, Flagship’s forward-thinking partnership aims to treat cardiometabolic, rare diseases
Novo Nordisk, Flagship’s forward-thinking partnership aims to treat cardiometabolic, rare [...]